ST
RXII

Spot Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Spot Trading’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,100
Closed -$5K – 3521
2016
Q3 		$5K Hold
13,100
– – ﹤0.01% 2948
2016
Q2 		$6K Buy
+13,100
New +$6K ﹤0.01% 3133
2015
Q1 		– Sell
-128,400
Closed -$194K – 4805
2014
Q4 		$194K Buy
128,400
+1,300
+1% +$1.96K ﹤0.01% 2944
2014
Q3 		$262K Sell
127,100
-1,200
-0.9% -$2.47K ﹤0.01% 3008
2014
Q2 		$393K Buy
128,300
+106,400
+486% +$326K ﹤0.01% 2878
2014
Q1 		$55K Buy
+21,900
New +$55K ﹤0.01% 3626
2013
Q3 		– Sell
-10,000
Closed -$22K – 4804
2013
Q2 		$22K Buy
+10,000
New +$22K ﹤0.01% 3861

Spot Trading's RXII Position: Q4 2016 in Review

Spot Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 5,650 shares — an estimated $2K sold.

Spot Trading first reported a position in RXII in Q2 2014 and held it in 3 quarters. The position peaked at $33K in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Spot Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 5,650 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $2K.
  • Spot Trading first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 3 quarters.
  • Spot Trading's GALENA BIOPHARMA INC COM position peaked at $33K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.